ArticleNeoplasia (New York, N.Y.)2012

Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.

Roger S Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.